Clément Gauvain

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 156 citations

Medicine, Neurology, Pharmacotherapy +14

Dominant-negative mutations in human <i>IL6ST</i> underlie hyper-IgE syndrome

Vivien Béziat, Simon J. Tavernier, Yin‐Huai Chen et al. · The Journal of Experimental Medicine · 2020 · 113 citations · Full text

Life Sciences, Genetics, Immunology +15

Intracerebral efficacy and tolerance of nivolumab in non–small-cell lung cancer patients with brain metastases

Clément Gauvain, E. Vauléon, C. Chouaïd et al. · Lung Cancer · 2017 · 108 citations

Medicine, Oncology, Pharmacology +14

Regulator of telomere length 1 (<i>RTEL1</i>) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes

Raphaël Borie, Diane Bouvry, Vincent Cottin et al. · European Respiratory Journal · 2018 · 71 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Pulmonary Arterial Histologic Lesions in Patients With COPD With Severe Pulmonary Hypertension

Vincent Bunel, Alice Guyard, Gaëlle Dauriat et al. · CHEST Journal · 2019 · 63 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12